Control of scarring in adult wounds by neutralising antibody to transforming growth factor beta.
about
Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategiesScar-free healing: from embryonic mechanisms to adult therapeutic interventionInflammation as a Keystone of Bone Marrow Stroma Alterations in Primary MyelofibrosisThe role of myofibroblasts in wound healing, contraction and its clinical implications in cleft palate repairThe Immune System in Tissue Environments Regaining Homeostasis after Injury: Is "Inflammation" Always Inflammation?Hypertrophic scar formation following burns and trauma: new approaches to treatmentFetuin/alpha2-HS glycoprotein is a transforming growth factor-beta type II receptor mimic and cytokine antagonistRecombinant soluble betaglycan is a potent and isoform-selective transforming growth factor-beta neutralizing agentAntibodies as therapeutic agents: vive la renaissance!Transforming growth factor: beta signaling is essential for limb regeneration in axolotlsNew molecular medicine-based scar management strategiesPlasma TGF beta in systemic sclerosis: a cross-sectional study.Scarless skin wound repair in the fetusThe effect of suramin on healing adult rodent dermal woundsNonsteroidal anti-inflammatory drugs for wounds: pain relief or excessive scar formation?Role of the HLA System in the Pathogenesis of Dupuytren's Disease.Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis.A review of fetal scarless healing.Hydrogen peroxide disrupts scarless fetal wound repair.Development of agents for the treatment of systemic sclerosis.Role of transforming growth factor Beta in corneal function, biology and pathologyWound remodelling and scarring.Cytokine blocking agents in dermatology.Traditional Japanese formula kigikenchuto accelerates healing of pressure-loading skin ulcer in rats.The impact of cyclooxygenase-2 mediated inflammation on scarless fetal wound healingAnti-scarring properties of different tryptophan derivativesSpecific growth factors and the healing of chronic wounds.Understanding the final stages of wound contraction.Evaluation of the effect of fractional CO2 laser on histopathological picture and TGF-β1 expression in hypertrophic scar.Suramin inhibits wound healing following filtering procedures for glaucoma.Evidence for a predominant proinflammatory conjunctival cytokine response in individuals with trachoma.Transforming growth factor-beta in disease: the dark side of tissue repair.Biologicals and fetal cell therapy for wound and scar management.Gene transfer of human hepatocyte growth factor into rat skin wounds mediated by liposomes coated with the sendai virus (hemagglutinating virus of Japan).Expression of transforming growth factor-beta 1 in dystrophic patient muscles correlates with fibrosis. Pathogenetic role of a fibrogenic cytokine.Enhanced expression of transforming growth factor-beta type I and type II receptors in wound granulation tissue and hypertrophic scar.Role of elevated plasma transforming growth factor-beta1 levels in wound healing.Cellular localization of transforming growth factor-beta expression in bleomycin-induced pulmonary fibrosisWound healing and inflammation: embryos reveal the way to perfect repairUrokinase receptor cleavage: a crucial step in fibroblast-to-myofibroblast differentiation.
P2860
Q24595036-AB09B641-42B5-4D9A-85D0-73D10EED8453Q24675326-4068DE04-E609-44CA-AB96-1AF8E7F484C7Q26774212-CA88DAFE-383A-4703-959C-593F39A28FF9Q27023860-412179CA-E052-45C2-B0F2-C131C2FC0DC6Q28066426-90CDE767-4E42-4A92-A6D4-CB520F4A8671Q28221076-1C52D3F9-73C2-474A-B8B2-185B5CDEB700Q28281644-1C176FB5-24FE-4FFE-B576-22D18303AAF3Q28360679-AB8EB942-866A-453D-B674-C953C35EA78FQ33193524-062B46B9-503B-4C65-9098-05675199DFA8Q33307528-ED4FC433-8101-43FB-AFC4-9B8296EA1D36Q33560989-73282E8F-5B93-47DF-A213-1CDE3978DDB6Q33566799-432C03C1-9AAA-4DD2-94CF-C6F857939AEEQ33581904-558CEDCB-C6B0-4038-9BF1-EE008EA42832Q33880834-239EBA22-E2FE-4B30-8714-3A5C2C033CD2Q34021948-A1CD42DE-88B0-46FF-877A-E78CD321C7DEQ34061326-97906722-0348-4301-AAD2-2BC91FAC45F3Q34229692-68949349-324E-497F-89FD-5E54A40DFAF4Q34279592-A2634F7C-D532-488A-B940-8795AE753143Q34452711-16F70934-DB0C-48F1-96E8-A68EBA583CFAQ34481552-0DE936CA-5F4B-4606-8ED0-D555252EE75AQ34623130-5C381955-397B-4305-B277-FA6CD9EADAF3Q34933375-A5CE62C8-2B9E-41C7-8C15-7E31F4399E13Q35015862-3E55060C-8C0A-4A1D-BE66-9919A3451B94Q35024708-6A76CEC4-DB64-4C90-8D5B-7D21B88977FDQ35103063-940AD62B-51F0-4F0C-A048-A4B42649A36FQ35122999-5A89B0B1-54EB-420E-9E39-A57E6C83DEAEQ35215303-AF99B60D-2647-41A2-BA94-6AF48724B132Q35215327-4724B54D-D1FE-4B47-880B-13633D24726CQ35241656-C5FE4809-67BB-4E85-80B1-DC753B9CDC10Q35306077-F219459D-DE96-4578-B569-8630AEECF6CAQ35512601-4DD30CAC-DDA0-4CFA-9CCC-CB5E7CBE3E64Q35603155-9FF1478F-3A53-4176-98AF-1CE2C09602AFQ35684319-F0F1A1C4-6C4A-4692-A3C9-E02DFC61BAA1Q35747709-3464140D-4E84-44D0-A7F7-B0F5CD4D197BQ35753459-C194FC3F-6CDF-4EBF-8B6C-84C6A29821EAQ35763720-980286AA-9C43-4CA5-8850-9ADC968F6D18Q35786858-1610C837-48B4-4604-9CB2-8F17B077E0B5Q35796092-F56CAEA9-752C-49E4-BDBC-4A7743F7E1EEQ35855738-54611028-1BFC-4034-B15B-3EFDAC4CF2A5Q35901840-78DC2D7A-621A-47C3-87A0-057F4EF2A731
P2860
Control of scarring in adult wounds by neutralising antibody to transforming growth factor beta.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh-hant
name
Control of scarring in adult w ...... ansforming growth factor beta.
@en
Control of scarring in adult w ...... ansforming growth factor beta.
@nl
type
label
Control of scarring in adult w ...... ansforming growth factor beta.
@en
Control of scarring in adult w ...... ansforming growth factor beta.
@nl
prefLabel
Control of scarring in adult w ...... ansforming growth factor beta.
@en
Control of scarring in adult w ...... ansforming growth factor beta.
@nl
P2093
P1433
P1476
Control of scarring in adult w ...... ansforming growth factor beta.
@en
P2093
P304
P356
10.1016/0140-6736(92)90009-R
P407
P577
1992-01-01T00:00:00Z